HealthCare Global Enterprises Limited (NSE:HCG)

India flag India · Delayed Price · Currency is INR
511.80
-2.85 (-0.55%)
Jan 31, 2025, 3:29 PM IST
42.17%
Market Cap 73.07B
Revenue (ttm) 20.44B
Net Income (ttm) 570.45M
Shares Out 139.35M
EPS (ttm) 4.06
PE Ratio 129.18
Forward PE 75.52
Dividend n/a
Ex-Dividend Date n/a
Volume 104,468
Average Volume 333,230
Open 514.50
Previous Close 514.65
Day's Range 507.90 - 520.10
52-Week Range 314.00 - 548.00
Beta 0.32
RSI 58.07
Earnings Date Feb 7, 2025

About NSE:HCG

HealthCare Global Enterprises Limited, together with its subsidiaries, provides medical and healthcare services focusing on cancer and fertility in India and internationally. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, including reproductive medicine, assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates multi-specialty hospitals under the HCG brand that provides inpatient and o... [Read more]

Sector Healthcare
Founded 1989
Employees 6,150
Stock Exchange National Stock Exchange of India
Ticker Symbol HCG
Full Company Profile

Financial Performance

In 2023, NSE:HCG's revenue was 19.12 billion, an increase of 12.85% compared to the previous year's 16.94 billion. Earnings were 481.55 million, an increase of 64.08%.

Financial Statements

News

HealthCare Global Enterprises Ltd (NSE:HCG) Q2 FY25 Earnings Call Highlights: Robust Revenue ...

HealthCare Global Enterprises Ltd (NSE:HCG) Q2 FY25 Earnings Call Highlights: Robust Revenue Growth and Strategic Digital Expansion

3 months ago - GuruFocus

Q2 2025 Healthcare Global Enterprises Ltd Earnings Call Transcript

Q2 2025 Healthcare Global Enterprises Ltd Earnings Call Transcript

3 months ago - GuruFocus

Healthcare Global Enterprises Q2 FY25 Results: Revenue at ₹552.47 Crore, Up 13.9% YoY; Profit at ₹20.68 Crore, Up 91.7% YoY

Healthcare Global Enterprises Ltd. reported its consolidated financial results for the second quarter of FY25, showing robust growth in both revenue and profit compared to the same quarter last year. ...

3 months ago - Business Upturn

Stocks to Watch on Oct 3: Reliance Power, Ashoka Buildcon, CESC, SMS Pharma, PVR INOX, Zydus Lifesciences, Reliance Infra, and HealthCare Global in focus

Key stocks to watch include Ashoka Buildcon, CESC, SMS Pharmaceuticals, PVR INOX, HealthCare Global Enterprises, Zydus Lifesciences, Reliance Power, Reliance Infra, Vikas Lifecare, Eraaya Lifespaces, ...

4 months ago - Business Upturn

HealthCare Global Enterprises completes acquisition of 51% stake in Vizag Hospital

HealthCare Global Enterprises Limited (HCG), a leading cancer care provider, has announced the completion of its acquisition of a 51% equity stake in Vizag Hospital and Cancer Research Centre Private ...

4 months ago - Business Upturn

Bain Is Said to Be Frontrunner For Indian Hospital Chain HCG

Bain Capital has emerged as the frontrunner to acquire a controlling stake in Indian cancer hospital chain HealthCare Global Enterprises Ltd., according to people familiar with the matter.

6 months ago - BNN Bloomberg